Attached files

file filename
8-K - FORM 8-K - Renovacor, Inc.ea122844-8k_charden.htm

 

Exhibit 99.1

 

CHARDAN HEALTHCARE ACQUISITION 2 CORP.

BALANCE SHEET

APRIL 28, 2020

 

       Pro Forma     
   April 28, 2020   Adjustments   As Adjusted 
       (unaudited)   (unaudited) 
ASSETS               
Current assets               
Cash  $1,128,077   $-     $1,128,077 
Prepaid expenses   96,800    -      96,800 
Total Current Assets   1,224,877    -      1,224,877 
                
Cash held in Trust Account   85,000,000    1,226,440    86,226,440 
Total Assets  $86,224,877   $1,226,440   $87,451,317 
                
LIABILITIES AND STOCKHOLDERS’ EQUITY               
Current liabilities               
Accrued expenses   16,747    -      16,747 
Accrued offering costs   35,000    -      35,000 
Promissory note – related party   30,000    -      30,000 
Total Current Liabilities   81,747    -      81,747 
                
Promissory note – related party   500,000    -      500,000 
Total Liabilities   581,747    -      581,747 
                
Commitments               
                
Common stock subject to possible redemption, 8,064,312 and 8,186,956 shares at redemption value, respectively   80,643,120    1,226,440    81,869,560 
                
Stockholders’ Equity               
Common stock, $0.0001 par value; 50,000,000 shares authorized; 2,879,438 and 2,591,349 shares issued and outstanding (excluding 8,064,312 and 8,186,956 shares subject to possible redemption), respectively   288    (29)   259 
Additional paid-in capital   5,019,115    29    5,019,144 
Accumulated deficit   (19,393)   -      (19,393)
Total Stockholders’ Equity   5,000,010    -      5,000,010 
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY  $86,224,877   $1,226,440   $87,451,317 

 

1